RHON-KLINIKUM AG Unsponsored ADR
RHON-KLINIKUM AG Unsponsored ADR
Your view on RKAGY
Overview
What the company does, where it operates, and who runs it.
About RHON-KLINIKUM AG Unsponsored ADR
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- CEO
- Stefan Stranz
- Headquarters
- Salzburger Leite 1, Bad Neustadt an der Saale, DE
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- CEO
- Stefan Stranz
- Headquarters
- Salzburger Leite 1, Bad Neustadt an der Saale, DE
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany.
Its hospitals offer treatment services, including rehabilitation of cardiovascular patients, hand surgery, neurological, psychosomatic, addiction therapy facilities, ophthalmology, trauma surgery, dentistry, thoracic, pulmonary, vascular, tumors, neurological conditions, and treatment of spinal column, joints, and heart diseases.
It operates eight hospitals and 5,420 beds/places at five medical sites. The company is based in Bad Neustadt an der Saale, Germany.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for RHON-KLINIKUM AG Unsponsored ADR, and the rating behind it. RKAGY last traded at $8.16, 22.7× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for RHON-KLINIKUM AG Unsponsored ADR. Starting points for RHON-KLINIKUM AG Unsponsored ADR: P/E 22.7, EPS $0.33, beta -0.05 — an Medical - Care Facilities name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for RHON-KLINIKUM AG Unsponsored ADR. RHON-KLINIKUM AG Unsponsored ADR does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for RHON-KLINIKUM AG Unsponsored ADR. Trailing twelve-month EPS for RHON-KLINIKUM AG Unsponsored ADR stands at $0.33. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for RHON-KLINIKUM AG Unsponsored ADR. RHON-KLINIKUM AG Unsponsored ADR has reported as a listed company since 2013. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
RHON-KLINIKUM AG Unsponsored ADR valued side by side against its closest peers. RHON-KLINIKUM AG Unsponsored ADR is measured against Medical - Care Facilities peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold RHON-KLINIKUM AG Unsponsored ADR, and how their positions are changing. At a $1.09B market value, institutional positions materially move RHON-KLINIKUM AG Unsponsored ADR's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by RHON-KLINIKUM AG Unsponsored ADR executives and directors. Shares of RHON-KLINIKUM AG Unsponsored ADR have traded between $6.05 and $9.07 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming RHON-KLINIKUM AG Unsponsored ADR. RHON-KLINIKUM AG Unsponsored ADR is a $1.09B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming RHON-KLINIKUM AG Unsponsored ADR. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for RHON-KLINIKUM AG Unsponsored ADR. Coverage tracks RHON-KLINIKUM AG Unsponsored ADR within Medical - Care Facilities (Healthcare). Press releases and market coverage, newest first.